Literature DB >> 7323812

Statistical contributions to phase II trials in cancer: interpretation, analysis and design.

Y J Lee, R A Wesley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7323812

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  6 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  An oriented phase-II trial of D-Trp6-LH-RH in patients with prostatic carcinoma.

Authors:  G Mathé; M L Vo Van; J Duchier; J L Misset; P Morin; R Keiling; L Schwarzenberg; P Kerbrat; E Achille; J C Tronc
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.

Authors:  R Metz; M Delgado; R Keiling; P Cappelaere; J P Armand; G Prevot; J L Misset; J Grimbert; G Mathe
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 5.  Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; M Clerici; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.

Authors:  Aurélien Dupré; David Melodelima; David Pérol; Yao Chen; Jérémy Vincenot; Jean-Yves Chapelon; Michel Rivoire
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.